EGFR-HER2 inhibitor Gefitinib hydrochloride, Purity ≥98%

Cat. No.: X24-05-ZQ652

EGFR-HER2 inhibitor Gefitinib hydrochloride, Purity ≥98%

Synonym: 184475-55-6; Iressa hydrochloride; ZD 1839 hydrochloride; ZD-1839 hydrochloride; ZD1839 hydrochloride; EGFR-HER2 inhibitor

  • CAS Number: 184475-55-6
Product Size
500 mg; 1000 mg; 2500 mg
Price
Datasheet
MSDS
Properties
Description
Gefitinib hydrochloride, soluble in DMSO, water and ethanol, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR.
Molecular Weight
483.36
Molecular Formula
C22H25Cl2FN4O3
Targets
EGFR
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 7 mg/mL (14.48 mM); Water: 1 mg/mL (2.06 mM); Ethanol: 1 mg/mL (2.06 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Gefitinib hydrochloride can be utilized to study its selective inhibition of EGFR and therapeutic potential in cancer.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.